(THLD:Consolidated Issue listed on NASDAQ Capital Market)
Stuart Holden M.D.
Scientific & Clinical Advisor, Threshold Pharmaceuticals Inc.
|Age||Total Calculated Compensation||This person is connected to 52 board members in 4 different organizations across 3 different industries.|
See Board Relationships
Dr. Stuart Holden is a Partner at Tower Urology and an Attending Surgeon at Cedars-Sinai Medical Center since 1978. He serves as a Scientific and Clinical Advisor of Threshold Pharmaceuticals, Inc. In addition to several research collaborations at Cedars-Sinai, Dr. Holden is the Principal Investigator of three innovative clinical trials of novel cancer therapies, which are being conducted at Tower Urology. He joined the UCLA clinical faculty in 1980. Previously, Dr. ...
170 Harbor WayPhone: 650-474-8200
South San Francisco, California 94080
Board Members Memberships*
Member of Scientific Advisory Board and Director
Clinical Advisor and Director
Concordia University, Wisconsin
Weill Cornell Medical College, New York
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|There is no Competitor Compensation data available.|